Jane Street’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.16M Buy
204,368
+103,428
+102% +$3.35M ﹤0.01% 3207
2025
Q4
$3.5M Buy
100,940
+60,670
+151% +$2.14M ﹤0.01% 3789
2025
Q3
$1.46M Sell
40,270
-141,909
-78% -$4.82M ﹤0.01% 5516
2025
Q2
$5.72M Buy
182,179
+129,517
+246% +$4.02M ﹤0.01% 2827
2025
Q1
$1.56M Sell
52,662
-38,723
-42% -$1.16M ﹤0.01% 4776
2024
Q4
$2.7M Sell
91,385
-80,682
-47% -$2.55M ﹤0.01% 3615
2024
Q3
$5.36M Buy
172,067
+39,454
+30% +$1.43M ﹤0.01% 2745
2024
Q2
$4.49M Buy
+132,613
New +$6.76M ﹤0.01% 3130
2024
Q1
Sell
-60,792
Closed -$4.17M 9606
2023
Q4
$4.15M Buy
60,792
+16,343
+37% +$849K ﹤0.01% 3130
2023
Q3
$2.31M Buy
44,449
+28,666
+182% +$1.7M ﹤0.01% 3816
2023
Q2
$946K Buy
+15,783
New +$901K ﹤0.01% 5266
2023
Q1
Sell
-14,883
Closed -$837K 9433
2022
Q4
$849K Sell
14,883
-35,805
-71% -$2.02M ﹤0.01% 5233
2022
Q3
$2.38M Buy
50,688
+2,224
+5% +$106K ﹤0.01% 3889
2022
Q2
$1.81M Buy
+48,464
New +$1.57M ﹤0.01% 4355

Other funds holding IMCR

Jane Street's IMCR Position: Q1 2026 in Review

Jane Street increased its Immunocore (IMCR) stake by 102% in Q1 2026, buying an estimated $3.35M and bringing the position to 204,368 shares worth $6.16M. The position accounts for ﹤0.01% of the portfolio, ranked #3207.

Jane Street first reported a position in IMCR in Q2 2022 and has held it in 14 quarters since. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Jane Street held 204,368 shares of Immunocore worth $6.16M as of Q1 2026.
  • Jane Street bought 103,428 Immunocore shares in Q1 2026, an estimated $3.35M.
  • Immunocore made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3207 holding.
  • Jane Street first reported a position in Immunocore in Q2 2022 and has held it in 14 quarters since.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.